Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Pharmacyclics Turns To Profit In Q1 - Quick Facts

RELATED NEWS
Trade PCYC now with 

Pharmacyclics Inc. (PCYC: Quote) reported that its first-quarter GAAP net income was $75.6 million, or $1.02 per share, compared to GAAP net loss of $14.5 million, or $0.21 loss per share in the year ago quarter.

The non-GAAP net income for the fiscal quarter was $78.8 million or $1.06 income per share, compared to a non-GAAP net loss of $12.4 million, or $0.18 per share last year.

Revenue for the quarter was $102.7 million, compared to $37,000 last year, an increase of approximately $102.7 million.

Revenue for the latest quarter consisted primarily of $100 million of license and milestone revenue due to the Company's achievement of two clinical milestones in connection with the Company's collaboration and license agreement with Janssen Biotech, Inc.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.75 per share on revenues of $87.64 million for the quarter. Analysts' estimates typically exclude special items.

Click here to receive FREE breaking news email alerts for Pharmacyclics Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
With traders reacting positively to the results of Scotland's independence referendum, stocks are likely to extend their recent upward move in early trading on Friday. The major index futures are currently pointing to a higher open for the markets, with the Dow futures up by 74 points. Testosterone, often considered as the "fountain of youth", is the major sex hormone in men, and as they age the level of this hormone also naturally declines. The condition in which the body doesn't produce enough testosterone is known as hypogonadism or simply, Low T. European Central Bank Executive Board Member Benoit Coeure and a Germany's Deputy Labor Minister Joerg Asmussen have urged Germany to cut taxes on wages and promote investment to revive the euro area economy. In a jointly-authored opinion piece for the German daily Berliner Zeitung and the French...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.